International Johnson & Johnson Reaches Largest Australian Product-Liability Class… Thomas Sullivan Nov 15, 2022 0 In September 2022, Johnson & Johnson reached a $204.90 million (A$300 million) settlement in two Australian class action…
Executive Branch Biden Administration Provides Update on Opioid Crisis Funding Thomas Sullivan Nov 14, 2022 0 In late September 2022, United States President Joe Biden released a statement regarding what his administration has done to help…
Transparency Turquoise Health Publishes Price Transparency Impact Report Thomas Sullivan Nov 11, 2022 0 On October 18, 2022, Turquoise Health published its Price Transparency Impact Report, which outlines the healthcare industry’s…
Drug Prices Biden Issues Executive Order on Drug Prices Thomas Sullivan Nov 10, 2022 0 On October 14, 2022, United States President Joe Biden issued an Executive Order on Lowering Prescription Drug Costs for…
Medical Legal Teva Reaches Settlement with Two More States Over Price-Fixing Allegations Thomas Sullivan Nov 9, 2022 0 On September 30, 2022, Teva Pharmaceuticals, reached an agreement with Chris Carr, the Attorney General of Georgia, to settle the…
Anti Kickback Pfizer Seeking to Rewrite Anti-Kickback Interpretations Thomas Sullivan Nov 8, 2022 0 In October 2022, Pfizer filed a petition with the Supreme Court of the United States, seeking to overturn a lower court decision…
HHS-OIG HHS OIG Finds that NIH Fails to Hold Researchers Accountable Thomas Sullivan Nov 7, 2022 0 The US Department of Health and Human Services (HHS) Office of Inspector General (OIG) says the National Institutes of Health…
Anti Kickback DOJ Announces $1.2 Million Settlement with Respironics Thomas Sullivan Nov 4, 2022 0 On September 22, 2022, the United States Department of Justice (DOJ) announced a $1.2 million settlement with Philips RS North…
FDA Drug Utilization Management Impacts Physician Treatment Decisions,… Thomas Sullivan Nov 3, 2022 0 A study recently published in PLOS ONE found that drug utilization management impacts physician treatment decisions and can lead…
FDA The Importance of Private Funding to Biopharmaceutical Development Thomas Sullivan Nov 2, 2022 0 In early September 2022, a study was published regarding The Relative Contributions of NIH and Private Sector Funding to the…